Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study

Atherosclerosis

Volumn 195, Issue 2, 2007, Pages 404-410

  Abdullah, Shuaib M ^a   Khera, Amit ^a   Leonard, David ^a   Das, Sandeep R ^a   Canham, Russell M ^a   Kamath, Sandeep A ^a   Vega, Gloria L ^a   Grundy, Scott M ^a   McGuire, Darren K ^a   de Lemos, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Inflammation; Leptin; Obesity; Sex differences

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; LEPTIN; MALE; MIDDLE AGED; OBESITY; SEX FACTORS; STATISTICS AS TOPIC;

EID: 36048966367     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.10.022     Document Type: Article

References (36)

1. Krauss R.M., Winston M., Fletcher B.J., et al. Obesity: impact on cardiovascular disease. Circulation 98 October (14) (1998) 1472-1476
2. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 October (14) (2002) 1723-1727
3. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 April (14) (1997) 973-979
4. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 April (14) (2004) 1387-1397
5. Visser M., Bouter L.M., McQuillan G.M., et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 December (22) (1999) 2131-2135
6. Castell J.V., Gomez-Lechon M.J., David M., et al. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology November (5) (1990) 1179-1186
7. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 December (25) (2001) 3052-3056
8. Gomez-Ambrosi J., Salvador J., Silva C., et al. Leptin therapy does not affect inflammatory markers. J Clin Endocrinol Metab 90 June (6) (2005) 3803
9. Gomez-Ambrosi J., Salvador J., Paramo J.A., et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 35 June (4) (2002) 315-320
10. Shamsuzzaman A.S., Winnicki M., Wolk R., et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109 May (18) (2004) 2181-2185
11. Matsubara M., Namioka K., and Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 148 June (6) (2003) 657-662
12. Ble A., Windham B.G., Bandinelli S., et al. Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). Am J Cardiol 96 October (7) (2005) 991-995
13. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46 August (3) (2005) 464-469
14. Pieroni L., Bastard J.P., Piton A., et al. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab 29 April (2 Pt 1) (2003) 133-138
15. Thorand B., Baumert J., Doring A., et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184 January (1) (2006) 216-224
16. Victor R.G., Haley R.W., Willett D.L., et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93 June (12) (2004) 1473-1480
17. Deo R., Khera A., McGuire D.K., et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 44 November (9) (2004) 1812-1818
18. de Lemos J.A., Zirlik A., Schonbeck U., et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol 25 October (10) (2005) 2192-2196
19. Das S.R., Drazner M.H., Dries D.L., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 October (14) (2005) 2163-2168
20. Reseland J.E., Anderssen S.A., Solvoll K., et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 73 February (2) (2001) 240-245
21. Heilbronn L.K., Noakes M., and Clifton P.M. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21 June (6) (2001) 968-970
22. Calabro P., Chang D.W., Willerson J.T., et al. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 46 September (6) (2005) 1112-1113
23. Calabro P., Willerson J.T., and Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 October (16) (2003) 1930-1932
24. Jabs W.J., Logering B.A., Gerke P., et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33 January (1) (2003) 152-161
25. Yasojima K., Schwab C., McGeer E.G., et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158 March (3) (2001) 1039-1051
26. Saad M.F., Damani S., Gingerich R.L., et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82 February (2) (1997) 579-584
27. Loffreda S., Yang S.Q., Lin H.Z., et al. Leptin regulates proinflammatory immune responses. FASEB J 12 January (1) (1998) 57-65
28. Zhang F., Basinski M.B., Beals J.M., et al. Crystal structure of the obese protein leptin-E100. Nature 387 May (6629) (1997) 206-209
29. Brabant G., Nave H., Horn R., et al. In vivo and in vitro evidence for a hepatic modulation of the leptin signal in rats. Eur J Clin Invest 34 December (12) (2004) 831-837
30. Dowidar N.L., Dejong C.H.C., Fearon K.C.H., Garden O.J., and Ross J.A. Effects of leptin on isolated human hepatocyte C reactive protein production. Eur J Gastroenterol Hepatol. 12 (2000) A18
31. Hukshorn C.J., Lindeman J.H., Toet K.H., et al. Leptin and the proinflammatory state associated with human obesity. J Clin Endocrinol Metab 89 April (4) (2004) 1773-1778
32. Chan J.L., Bullen J., Stoyneva V., et al. Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess. J Clin Endocrinol Metab 90 March (3) (2005) 1618-1624
33. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20 September (9) (2000) 2094-2099
34. Trion A., de Maat M.P., Jukema J.W., et al. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol 25 August (8) (2005) 1635-1640
35. Khera A., de Lemos J.A., Peshock R.M., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113 January (1) (2006) 38-43
36. Langenberg C., Bergstrom J., Scheidt-Nave C., et al. Cardiovascular death and the metabolic syndrome: role of adiposity-signaling hormones and inflammatory markers. Diabetes Care 29 June (6) (2006) 1363-1369